AI 'Liquid Biopsies' Using Cell-Free DNA, Protein Biomarkers, Could Aid Early Detection of Ovarian Cancer

Las 'biopsias líquidas' de IA que utilizan ADN libre de células y biomarcadores proteicos podrían ayudar a la detección temprana del cáncer de ovario

AI ‘Liquid Biopsies’ Using Cell-Free DNA, Protein Biomarkers, Could Aid Early Detection of Ovarian Cancer

Un análisis de sangre que utiliza inteligencia artificial (IA) para detectar cambios genéticos relacionados con el cáncer y biomarcadores proteicos podría ayudar a detectar en las mujeres signos tempranos de cáncer de ovario, según un estudio realizado por investigadores del Centro Oncológico Johns Hopkins Kimmel en colaboración con varias otras instituciones de Estados Unidos y Europa.

APRENDE MÁS

VER TODAS LAS NOTICIAS

Mensajes recientes

New Technology: MRI-guided Focused Ultrasound for Prostate Cancer Advances in Breast Cancer Treatment: Insights from Medical Oncologist Jenni Sheng Early Immunotherapy Shows Promising Results in Advanced Basal Cell Carcinoma New NIH-Funded Johns Hopkins Medicine Study Finds High-Risk Individuals Who Have Mild Dilatation of the Pancreatic Duct Have Increased Risk for Pancreatic Cancer Lung Cancer Symptoms Doctors Say Women Should Never Ignore and the Screening Most Skip Targeted Radiation During Surgery Reduces Pancreatic Cancer Recurrence Colorectal Cancer Is Becoming More Common In Young People. Here Are The Signs. Johns Hopkins-Led Study Finds Drugs Approved for Treating Pain Also Reduce Bone Cancer Growth DNA Shed by Colon Cancers May Help Oncologists Personalize Postsurgical Treatment